Post-marketing Safety and Efficacy Evaluation of a Novel Drug CSE-1034: A Drug-use Analysis in Paediatric Patients with Hospital-acquired Pneumonia
Introduction: Hospital-Acquired Pneumonia (HAP) is one of the common and frequently reported nosocomial infections with potential life-threatening complications in paediatric group. One of the drugs approved for treatment of various bacterial infections in all age groups is CSE-1034 (Ceftriaxone+Sul...
Main Authors: | Manu Chaudhary, Shiekh Gazalla Ayub, Mohd Amin Mir |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2018-09-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/12059/31549_CE[Ra]_F(Sh)_PF1(AB_SS)_PFA(SHU)_PB(NC_SHU)_PN(SL).pdf |
Similar Items
-
Comparative efficacy and safety analysis of CSE-1034: An open labeled phase III study in community acquired pneumonia
by: Manu Chaudhary, et al.
Published: (2018-09-01) -
Inhaled colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A real-life experience in tertiary care hospitals in Saudi Arabia
by: Thamer A. Almangour, et al.
Published: (2020-08-01) -
Antimicrobial resistance of Gram-negative pathogens of nosocomial pneumonia in intensive care unit patients
by: Pervukhin S.A., et al.
Published: (2019-02-01) -
CSE-1034 versus ceftriaxone: Efficacy and safety analysis from a randomized, open-labeled phase III study in complicated urinary tract infections
by: Manu Chaudhary, et al.
Published: (2018-01-01) -
Hospital Acquired Pneumonia
by: Halis AKALIN, et al.
Published: (1999-12-01)